AAAAAA

   
Results: 1-25 | 26-50 | 51-55
Results: 26-50/55
EVALUATION OF THE EFFECTIVENESS OF 3 SCREENING METHODS FOR COLORECTALNEOPLASM
Authors: YOSHINAGA M MOTOMURA S OHTANI A
Citation: M. Yoshinaga et al., EVALUATION OF THE EFFECTIVENESS OF 3 SCREENING METHODS FOR COLORECTALNEOPLASM, Gastroenterology, 112(4), 1997, pp. 687-687
EFFECT OF GRAPEFRUIT JUICE ON THE DISPOSITION OF NICARDIPINE AFTER ADMINISTRATION OF INTRAVENOUS AND ORAL DOSES
Authors: UNO T OHKUBO T SUGAWARA K HIGASHIYAMA A MOTOMURA S
Citation: T. Uno et al., EFFECT OF GRAPEFRUIT JUICE ON THE DISPOSITION OF NICARDIPINE AFTER ADMINISTRATION OF INTRAVENOUS AND ORAL DOSES, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 60-60
INTERSTITIAL PNEUMONIA IN PATIENTS RECEIVING GRANULOCYTE-COLONY-STIMULATING FACTOR DURING CHEMOTHERAPY - SURVEY IN JAPAN 1991-96
Authors: NIITSU N IKI S MUROI K MOTOMURA S MURAKAMI M TAKEYAMA H OHSAKA A URABE A
Citation: N. Niitsu et al., INTERSTITIAL PNEUMONIA IN PATIENTS RECEIVING GRANULOCYTE-COLONY-STIMULATING FACTOR DURING CHEMOTHERAPY - SURVEY IN JAPAN 1991-96, British Journal of Cancer, 76(12), 1997, pp. 1661-1666
INHIBITORS AND THERAPEUTIC STRATEGIES OF ACQUIRED VON-WILLEBRAND-DISEASE
Authors: MOHRI H MOTOMURA S KANAMORI H MATSUZAKI M WATANABE S MARUTA A KODAMA F OKUBO T
Citation: H. Mohri et al., INHIBITORS AND THERAPEUTIC STRATEGIES OF ACQUIRED VON-WILLEBRAND-DISEASE, Blood, 90(10), 1997, pp. 137-137
ACQUIRED TYPE 2A VON-WILLEBRAND DISEASE IN CHRONIC MYELOCYTIC-LEUKEMIA
Authors: MOHRI H TANABE J YAMAZAKI E YOSHIDA M HARANO H MATSUZAKI M MOTOMURA S OKUBO T
Citation: H. Mohri et al., ACQUIRED TYPE 2A VON-WILLEBRAND DISEASE IN CHRONIC MYELOCYTIC-LEUKEMIA, Hematopathology and molecular hematology, 10(3), 1996, pp. 123-133
CHRONIC MYELOCYTIC-LEUKEMIA FOLLOWING ULCERATIVE-COLITIS
Authors: FUJISAWA S MOTOMURA S FUJIMAKI K MOHRI H OKUBO T
Citation: S. Fujisawa et al., CHRONIC MYELOCYTIC-LEUKEMIA FOLLOWING ULCERATIVE-COLITIS, International journal of hematology, 63(3), 1996, pp. 241-242
DNA TOPOISOMERASE-II INHIBITORS ENHANCE RANDOM INTEGRATION OF TRANSFECTED VECTORS INTO HUMAN-CHROMOSOMES
Authors: FUJIMAKI K ARATANI Y FUJISAWA S MOTOMURA S OKUBO T KOYAMA H
Citation: K. Fujimaki et al., DNA TOPOISOMERASE-II INHIBITORS ENHANCE RANDOM INTEGRATION OF TRANSFECTED VECTORS INTO HUMAN-CHROMOSOMES, Somatic cell and molecular genetics, 22(4), 1996, pp. 279-290
HEMATOLOGIC BENEFITS OF 1-HYDROXYVITAMIN D-3 IN AN ELDERLY PATIENT WITH CHRONIC MYELODYSPLASTIC SYNDROME
Authors: MOTOMURA S FUJISAWA S TSUNOOKA S FUJIMAKI K MOHRI H OKUBO T
Citation: S. Motomura et al., HEMATOLOGIC BENEFITS OF 1-HYDROXYVITAMIN D-3 IN AN ELDERLY PATIENT WITH CHRONIC MYELODYSPLASTIC SYNDROME, American journal of hematology, 53(2), 1996, pp. 143-144
TRANSLOCATION-21-22 MAY BE INVOLVED IN CONTROL OF DIFFERENTIATION IN ERYTHROLEUKEMIA
Authors: FUJISAWA S MOTOMURA S FUJIMAKI K OKUBO T
Citation: S. Fujisawa et al., TRANSLOCATION-21-22 MAY BE INVOLVED IN CONTROL OF DIFFERENTIATION IN ERYTHROLEUKEMIA, American journal of hematology, 52(1), 1996, pp. 65-65
USE OF ANTISENSE OLIGONUCLEOTIDES TO HUMAN MULTIDRUG-RESISTANCE GENE (MDR1) TO INHIBIT P-GLYCOPROTEIN OF HUMAN ACUTE MYELOGENOUS LEUKEMIC BLASTS IN-VITRO
Authors: MOTOMURA S MOTOII T WANG Y YAMATO I TAKANASHI M SHIOZAKI H MIZOGUCHI H
Citation: S. Motomura et al., USE OF ANTISENSE OLIGONUCLEOTIDES TO HUMAN MULTIDRUG-RESISTANCE GENE (MDR1) TO INHIBIT P-GLYCOPROTEIN OF HUMAN ACUTE MYELOGENOUS LEUKEMIC BLASTS IN-VITRO, Experimental hematology, 24(9), 1996, pp. 152-152
EXPRESSION OF MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) AND MULTIDRUG-RESISTANCE GENE (MDR1) ON BLAST CELLS WITH ACUTE-LEUKEMIA AND ITSRELATIONSHIP WITH DRUG-SENSITIVITY AND CLINICAL OUTCOME
Authors: MOTOJI T ARAI T WANG Y MOTOMURA S YAMATO I TAKANASHI M
Citation: T. Motoji et al., EXPRESSION OF MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) AND MULTIDRUG-RESISTANCE GENE (MDR1) ON BLAST CELLS WITH ACUTE-LEUKEMIA AND ITSRELATIONSHIP WITH DRUG-SENSITIVITY AND CLINICAL OUTCOME, Experimental hematology, 24(9), 1996, pp. 296-296
NOVEL SYNTHETIC PEPTIDES FROM THE C-TERMINAL HEPARIN-BINDING DOMAIN OF FIBRONECTIN WITH HEPARIN-BINDING ACTIVITY
Authors: MOHRI H KATOH K MOTOMURA S OKUBO T
Citation: H. Mohri et al., NOVEL SYNTHETIC PEPTIDES FROM THE C-TERMINAL HEPARIN-BINDING DOMAIN OF FIBRONECTIN WITH HEPARIN-BINDING ACTIVITY, Peptides, 17(6), 1996, pp. 1079-1081
COMPARISON OF DIRECT NEGATIVE CHRONOTROPIC AND POSITIVE INOTROPIC EFFECTS OF SEMATILIDE TO THOSE OF E-4031 AND MS-551 AND THE REVERSE FREQUENCY-DEPENDENT PROLONGATION OF CARDIAC REFRACTORINESS OF SEMATILIDE
Authors: YAMADA A MOTOMURA S HASHIMOTO K
Citation: A. Yamada et al., COMPARISON OF DIRECT NEGATIVE CHRONOTROPIC AND POSITIVE INOTROPIC EFFECTS OF SEMATILIDE TO THOSE OF E-4031 AND MS-551 AND THE REVERSE FREQUENCY-DEPENDENT PROLONGATION OF CARDIAC REFRACTORINESS OF SEMATILIDE, Journal of cardiovascular pharmacology, 27(1), 1996, pp. 159-166
GROWTH-STIMULATORY EFFECT OF THROMBOPOIETIN ON THE BLAST CELLS OF ACUTE MYELOGENOUS LEUKEMIA
Authors: MOTOJI T TAKANASHI M MOTOMURA S WANG YH SHIOZAKI H AOYAMA M MIZOGUCHI H
Citation: T. Motoji et al., GROWTH-STIMULATORY EFFECT OF THROMBOPOIETIN ON THE BLAST CELLS OF ACUTE MYELOGENOUS LEUKEMIA, British Journal of Haematology, 94(3), 1996, pp. 513-516
ACQUIRED VON-WILLEBRAND DISEASE-ASSOCIATED WITH MULTIPLE-MYELOMA - CHARACTERIZATION OF AN INHIBITOR TO VON-WILLEBRAND-FACTOR
Authors: MOHRI H TANABE J OHTSUKA M YOSHIDA M MOTOMURA S NISHIDA S FUJIMURA Y OKUBO T
Citation: H. Mohri et al., ACQUIRED VON-WILLEBRAND DISEASE-ASSOCIATED WITH MULTIPLE-MYELOMA - CHARACTERIZATION OF AN INHIBITOR TO VON-WILLEBRAND-FACTOR, Blood coagulation & fibrinolysis, 6(6), 1995, pp. 561-566
INTERACTIONS OF A NEW BETA-BLOCKER, CELIPROLOL, WITH THE CALCIUM-ANTAGONISTS, DILTIAZEM AND NIFEDIPINE, ON ATRIOVENTRICULAR-CONDUCTION
Authors: MOTOMURA S HASHIMOTO K
Citation: S. Motomura et K. Hashimoto, INTERACTIONS OF A NEW BETA-BLOCKER, CELIPROLOL, WITH THE CALCIUM-ANTAGONISTS, DILTIAZEM AND NIFEDIPINE, ON ATRIOVENTRICULAR-CONDUCTION, Cardiovascular drugs and therapy, 9(3), 1995, pp. 445-457
INTERSTITIAL PNEUMONIA INDUCED BY COMBINATION THERAPY WITH LOW-DOSE CYTARABINE AND GRANULOCYTE-COLONY-STIMULATING FACTOR
Authors: MOTOMURA S FUJISAWA S FUJIMAKI K MOHRI H OKUBO T
Citation: S. Motomura et al., INTERSTITIAL PNEUMONIA INDUCED BY COMBINATION THERAPY WITH LOW-DOSE CYTARABINE AND GRANULOCYTE-COLONY-STIMULATING FACTOR, American journal of hematology, 49(4), 1995, pp. 364-364
SUCCESSFUL TREATMENT OF CD7-POSITIVE, UNDIFFERENTIATED ACUTE-LEUKEMIAWITH RECOMBINANT INTERFERON-ALPHA
Authors: SASAKI S FUKAWA H MOTOMURA S MOHRI H OHKUBO T KATAYAMA R
Citation: S. Sasaki et al., SUCCESSFUL TREATMENT OF CD7-POSITIVE, UNDIFFERENTIATED ACUTE-LEUKEMIAWITH RECOMBINANT INTERFERON-ALPHA, American journal of hematology, 48(3), 1995, pp. 203-204
EFFECT OF C-MPL LIGAND ON THE PROLIFERATION OF BLAST CELLS FROM ACUTEMYELOGENOUS LEUKEMIA
Authors: MOTOJI T MOTOMURA S WANG Y TAKANASHI M HIZOGUCHI H
Citation: T. Motoji et al., EFFECT OF C-MPL LIGAND ON THE PROLIFERATION OF BLAST CELLS FROM ACUTEMYELOGENOUS LEUKEMIA, Experimental hematology, 23(8), 1995, pp. 885-885
RECOVERY OF DRUG-SENSITIVITY BY MS-209 ON DRUG-RESISTANT ACUTE MYELOGENOUS LEUKEMIC-CELLS
Authors: WANG Y MOTOJI T MOTOMURA S HIZOGUCHI H
Citation: Y. Wang et al., RECOVERY OF DRUG-SENSITIVITY BY MS-209 ON DRUG-RESISTANT ACUTE MYELOGENOUS LEUKEMIC-CELLS, Experimental hematology, 23(8), 1995, pp. 929-929
EVALUATION OF THE SENSITIVITY OF AN IMMUNOCHEMICAL FECAL OCCULT BLOOD-TEST FOR COLORECTAL NEOPLASIA
Authors: YOSHINAGA M MOTOMURA S TAKEDA H YANAGISAWA Z IKEDA K
Citation: M. Yoshinaga et al., EVALUATION OF THE SENSITIVITY OF AN IMMUNOCHEMICAL FECAL OCCULT BLOOD-TEST FOR COLORECTAL NEOPLASIA, The American journal of gastroenterology, 90(7), 1995, pp. 1076-1079
PREDICTING RELAPSE OF CHRONIC MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION BY BCR-ABL MESSENGER-RNA AND DNA-FINGERPRINTING
Authors: OKAMOTO R HARANO H MATSUZAKI M MOTOMURA S MARUTA A KODAMA F MOHRI H OKUBO T
Citation: R. Okamoto et al., PREDICTING RELAPSE OF CHRONIC MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION BY BCR-ABL MESSENGER-RNA AND DNA-FINGERPRINTING, American journal of clinical pathology, 104(5), 1995, pp. 510-516
SUCCESSFUL TREATMENT OF LOW-DOSE CYTOSINE-ARABINOSIDE FOR ACUTE MYELOFIBROSIS WITH IMMATURE MYELOBLAST (AML-MO)
Authors: KANAMORI H TANABE J KOIKE T HASHIMOTO Y MATSUZAKI M KITAMURA H MOTOMURA S MOHRI H OHKUBO T
Citation: H. Kanamori et al., SUCCESSFUL TREATMENT OF LOW-DOSE CYTOSINE-ARABINOSIDE FOR ACUTE MYELOFIBROSIS WITH IMMATURE MYELOBLAST (AML-MO), American journal of hematology, 46(2), 1994, pp. 154-155
LIVER-FUNCTION TESTS OF RECIPIENTS WITH HEPATITIS-C VIRUS-INFECTION AFTER BONE-MARROW TRANSPLANTATION
Authors: MARUTA A KANAMORI H FUKAWA H HARANO H MATSUZAKI M MIYASHITA H FUJISAWA S NOGUCHI T OGAWA K SAKAI R MOTOMURA S KODAMA F OKUBO T SEKIYAMA K YOSHIBA M HORI M
Citation: A. Maruta et al., LIVER-FUNCTION TESTS OF RECIPIENTS WITH HEPATITIS-C VIRUS-INFECTION AFTER BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 13(4), 1994, pp. 417-422
UTILIZATION OF AN ISOLATED, BLOOD-PERFUSED CANINE PAPILLARY-MUSCLE PREPARATION AS A MODEL TO ASSESS EFFICACY AND ADVERSITY OF CLASS-I ANTIARRHYTHMIC DRUGS
Authors: SUGIYAMA A MOTOMURA S HASHIMOTO K
Citation: A. Sugiyama et al., UTILIZATION OF AN ISOLATED, BLOOD-PERFUSED CANINE PAPILLARY-MUSCLE PREPARATION AS A MODEL TO ASSESS EFFICACY AND ADVERSITY OF CLASS-I ANTIARRHYTHMIC DRUGS, Japanese Journal of Pharmacology, 66(3), 1994, pp. 303-316
Risultati: 1-25 | 26-50 | 51-55